Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer

NCT00332709 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis
Postmenopausal

Interventions

DRUG: Letrozole
DRUG: Zoledronic acid

Sponsor

Novartis